220 related articles for article (PubMed ID: 30414097)
1. A cancer tissue-specific FAM72 expression profile defines a novel glioblastoma multiform (GBM) gene-mutation signature.
Rahane CS; Kutzner A; Heese K
J Neurooncol; 2019 Jan; 141(1):57-70. PubMed ID: 30414097
[TBL] [Abstract][Full Text] [Related]
2. FAM72, Glioblastoma Multiforme (GBM) and Beyond.
Ho NTT; Rahane CS; Pramanik S; Kim PS; Kutzner A; Heese K
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33804473
[TBL] [Abstract][Full Text] [Related]
3. All-or-(N)One - an epistemological characterization of the human tumorigenic neuronal paralogous FAM72 gene loci.
Kutzner A; Pramanik S; Kim PS; Heese K
Genomics; 2015 Nov; 106(5):278-85. PubMed ID: 26206078
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.
Han J; Puri RK
J Neurooncol; 2018 Feb; 136(3):463-474. PubMed ID: 29168083
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.
Rahman MH; Rana HK; Peng S; Hu X; Chen C; Quinn JMW; Moni MA
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406529
[TBL] [Abstract][Full Text] [Related]
6. Expression and prognostic significance of TCTN1 in human glioblastoma.
Meng D; Chen Y; Zhao Y; Wang J; Yun D; Yang S; Chen J; Chen H; Lu D
J Transl Med; 2014 Oct; 12():288. PubMed ID: 25304031
[TBL] [Abstract][Full Text] [Related]
7. Integration of RNA-Seq and proteomics data identifies glioblastoma multiforme surfaceome signature.
Syafruddin SE; Nazarie WFWM; Moidu NA; Soon BH; Mohtar MA
BMC Cancer; 2021 Jul; 21(1):850. PubMed ID: 34301218
[TBL] [Abstract][Full Text] [Related]
8. CDC6 is up-regulated and a poor prognostic signature in glioblastoma multiforme.
Zhao H; Zhou X; Yuan G; Hou Z; Sun H; Zhai N; Huang B; Li X
Clin Transl Oncol; 2021 Mar; 23(3):565-571. PubMed ID: 32661826
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing.
Fan F; Zhang H; Dai Z; Zhang Y; Xia Z; Cao H; Yang K; Hu S; Guo Y; Ding F; Cheng Q; Zhang N
Cell Oncol (Dordr); 2021 Aug; 44(4):917-935. PubMed ID: 34142341
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
Luedi MM; Singh SK; Mosley JC; Hassan ISA; Hatami M; Gumin J; Andereggen L; Sulman EP; Lang FF; Stueber F; Fuller GN; Colen RR; Zinn PO
J Neurosurg; 2018 Dec; 129(6):1446-1455. PubMed ID: 29328002
[TBL] [Abstract][Full Text] [Related]
11. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of polycomb group genes in glioblastoma multiforme.
Li G; Warden C; Zou Z; Neman J; Krueger JS; Jain A; Jandial R; Chen M
PLoS One; 2013; 8(11):e80970. PubMed ID: 24260522
[TBL] [Abstract][Full Text] [Related]
13. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L
Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456
[TBL] [Abstract][Full Text] [Related]
14. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients.
Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F
J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911
[TBL] [Abstract][Full Text] [Related]
15. A 63 signature genes prediction system is effective for glioblastoma prognosis.
Zhang Y; Xu J; Zhu X
Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
[TBL] [Abstract][Full Text] [Related]
16. Identification of a panel of genes as a prognostic biomarker for glioblastoma.
Wang F; Zheng Z; Guan J; Qi D; Zhou S; Shen X; Wang F; Wenkert D; Kirmani B; Solouki T; Fonkem E; Wong ET; Huang JH; Wu E
EBioMedicine; 2018 Nov; 37():68-77. PubMed ID: 30341039
[TBL] [Abstract][Full Text] [Related]
17. ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma.
Dréan A; Rosenberg S; Lejeune FX; Goli L; Nadaradjane AA; Guehennec J; Schmitt C; Verreault M; Bielle F; Mokhtari K; Sanson M; Carpentier A; Delattre JY; Idbaih A
J Neurooncol; 2018 Jul; 138(3):479-486. PubMed ID: 29520610
[TBL] [Abstract][Full Text] [Related]
18. FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma.
Yu Y; Wang Z; Zheng Q; Li J
Aging (Albany NY); 2021 Mar; 13(6):8155-8176. PubMed ID: 33686947
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets.
Hoelzinger DB; Mariani L; Weis J; Woyke T; Berens TJ; McDonough WS; Sloan A; Coons SW; Berens ME
Neoplasia; 2005 Jan; 7(1):7-16. PubMed ID: 15720813
[TBL] [Abstract][Full Text] [Related]
20. Integrative analysis of DNA methylation and gene expression to identify key epigenetic genes in glioblastoma.
Jia D; Lin W; Tang H; Cheng Y; Xu K; He Y; Geng W; Dai Q
Aging (Albany NY); 2019 Aug; 11(15):5579-5592. PubMed ID: 31395792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
